The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed a booster shot of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older, some adults with underlying medical conditions, and some adults in high-risk working and institutional settings.
